Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Radiation Oncology

When is it appropriate to treat splenic metastasis with radiation?

What dose/ fractionation is recommended?

Related Questions

Do TTFields work synergistically with SRS for patients with brain metastases?

For stage III-IV Hodgkin's lymphoma, would you consider consolidative radiation for bulky disease after a complete response was seen using N-AVD per the S1826 trial?

In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?

Would you hold HAI/ FUDR for SBRT of a residual liver metastasis following hepatic metastasectomy?

How do you manage a symptomatic primary breast tumor in a patient with metastatic disease?

When treating an inoperable urothelial cancer of the renal pelvis, what are your considerations when determining candidacy for SBRT?

Would you include the tract in your treatment field in a patient with squamous cell carcinoma of the anal canal presenting with an ano-cutaneous fistula?

How have you incorporated ctDNA into the clinical management of patients with gynecologic cancers?

Do you recommend neoadjuvant 177Lu-PNT2002 followed by MDT per the LUNAR trial as your preferred treatment approach for oligorecurrent prostate cancer, as opposed to MDT and PSMA-radioligand therapy used as temporally separate treatments?

How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?

Copyright © 2026 theMednet
All Rights Reserved.